Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Oct;36(10):2253–2258. doi: 10.1128/aac.36.10.2253

Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication.

M Hughes-Fulford 1, M S McGrath 1, D Hanks 1, S Erickson 1, L Pulliam 1
PMCID: PMC245485  PMID: 1332592

Abstract

We have investigated the direct effect of dimethyl prostaglandin A1 (dmPGA1) on the replication of herpes simplex virus (HSV) and human immunodeficiency virus type 1 (HIV-1). dmPGA1 significantly inhibited viral replication in both HSV and HIV infection systems at concentrations of dmPGA1 that did not adversely alter cellular DNA synthesis. The 50% inhibitory concentration (ID50) for several HSV type 1 (HSV-1) strains ranged from 3.8 to 5.6 micrograms/ml for Vero cells and from 4.6 to 7.3 micrograms/ml for human foreskin fibroblasts. The ID50s for two HSV-2 strains varied from 3.8 to 4.5 micrograms/ml for Vero cells; the ID50 was 5.7 micrograms/ml for human foreskin fibroblasts. We found that closely related prostaglandins did not have the same effect on the replication of HSV; dmPGE2 and dmPGA2 caused up to a 60% increase in HSV replication compared with that in untreated virus-infected cells. HIV-1 replication in acutely infected T cells (VB line) and chronically infected macrophages was assessed by quantitative decreases in p24 concentration. The effective ID50s were 2.5 micrograms/ml for VB cells acutely infected with HIV-1 and 5.2 micrograms/m for chronically infected macrophages. dmPGA1 has an unusual broad-spectrum antiviral activity against both HSV and HIV-1 in vitro and offers a new class of potential therapeutic agents for in vivo use.

Full text

PDF
2253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker D. A., Thomas J., Epstein J., Possilico D., Stone M. L. The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro. Am J Obstet Gynecol. 1982 Oct 1;144(3):346–349. doi: 10.1016/0002-9378(82)90589-0. [DOI] [PubMed] [Google Scholar]
  2. Bhuyan B. K., Adams E. G., Badiner G. J., Li L. H., Barden K. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. Cancer Res. 1986 Apr;46(4 Pt 1):1688–1693. [PubMed] [Google Scholar]
  3. Bregman M. D., Meyskens F. L., Jr Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1. Cancer Res. 1983 Apr;43(4):1642–1645. [PubMed] [Google Scholar]
  4. Emau P., Giri S. N., Bruss M. L. Viral-bacterial pneumonia in calves: effects on plasma eicosanoids and long chain fatty acids. Int J Tissue React. 1987;9(3):199–214. [PubMed] [Google Scholar]
  5. Hakeda Y., Yoshino T., Natakani Y., Kurihara N., Maeda N., Kumegawa M. Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J Cell Physiol. 1986 Aug;128(2):155–161. doi: 10.1002/jcp.1041280204. [DOI] [PubMed] [Google Scholar]
  6. Harbour D. A., Blyth W. A., Hill T. J. Prostanglandins enhance spread of herpes simplex virus in cell cultures. J Gen Virol. 1978 Oct;41(1):87–95. doi: 10.1099/0022-1317-41-1-87. [DOI] [PubMed] [Google Scholar]
  7. Jee W. S., Ueno K., Deng Y. P., Woodbury D. M. The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int. 1985 Mar;37(2):148–157. doi: 10.1007/BF02554834. [DOI] [PubMed] [Google Scholar]
  8. Kunkel S. L., Spengler M., May M. A., Spengler R., Larrick J., Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988 Apr 15;263(11):5380–5384. [PubMed] [Google Scholar]
  9. Kuno S., Ueno R., Hayaishi O., Nakashima H., Harada S., Yamamoto N. Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro. Proc Natl Acad Sci U S A. 1986 May;83(10):3487–3490. doi: 10.1073/pnas.83.10.3487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McGrath M. S., Hwang K. M., Caldwell S. E., Gaston I., Luk K. C., Wu P., Ng V. L., Crowe S., Daniels J., Marsh J. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2844–2848. doi: 10.1073/pnas.86.8.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  12. Ohno K., Fukushima M., Fujiwara M., Narumiya S. Induction of 68,000-dalton heat shock proteins by cyclopentenone prostaglandins. Its association with prostaglandin-induced G1 block in cell cycle progression. J Biol Chem. 1988 Dec 25;263(36):19764–19770. [PubMed] [Google Scholar]
  13. Santoro M. G., Benedetto A., Carruba G., Garaci E., Jaffe B. M. Prostaglandin A compounds as antiviral agents. Science. 1980 Aug 29;209(4460):1032–1034. doi: 10.1126/science.6157190. [DOI] [PubMed] [Google Scholar]
  14. Santoro M. G., Garaci E., Amici C. Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8407–8411. doi: 10.1073/pnas.86.21.8407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Santoro M. G., Jaffe B. M., Esteban M. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. J Gen Virol. 1983 Dec;64(Pt 12):2797–2801. doi: 10.1099/0022-1317-64-12-2797. [DOI] [PubMed] [Google Scholar]
  16. Santoro M. G., Jaffe B. M., Garaci E., Esteban M. Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells. J Gen Virol. 1982 Dec;63(2):435–440. doi: 10.1099/0022-1317-63-2-435. [DOI] [PubMed] [Google Scholar]
  17. Trofatter K. F., Jr, Daniels C. A. Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infect Immun. 1980 Jan;27(1):158–167. doi: 10.1128/iai.27.1.158-167.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wahl L. M., Corcoran M. L., Pyle S. W., Arthur L. O., Harel-Bellan A., Farrar W. L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A. 1989 Jan;86(2):621–625. doi: 10.1073/pnas.86.2.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wiley M. H., Feingold K. R., Grunfeld C., Quesney-Huneeus V., Wu J. M. Evidence for cAMP-independent inhibition of S-phase DNA synthesis by prostaglandins. J Biol Chem. 1983 Jan 10;258(1):491–496. [PubMed] [Google Scholar]
  20. Yamamoto N., Fukushima M., Tsurumi T., Maeno K., Nishiyama Y. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1425–1431. doi: 10.1016/0006-291x(87)90809-6. [DOI] [PubMed] [Google Scholar]
  21. Yamamoto N., Harada S., Nakashima H. Substances affecting the infection and replication of human immunodeficiency virus (HIV). AIDS Res. 1986 Dec;2 (Suppl 1):S183–S189. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES